Case study: Oral form with accelerated bioavailability of paracetamol and aspirin A Pharmaceutical company wants to develop and manufacture an oral form with accelerated bioavailability containing paracetamol (300 mg) and aspirin (200 mg). Taking into account the physicochemical characteristics of these active ingredients, propose and justify a formulation, a choice of excipients, a method of […]